DAVOLASH USULLARINING KO‘Z YOSHI PLYONKASI BARQARORLIGIGA TA’SIRINI QIYOSIY TAHLIL QILISH
Keywords:
Kalit so‘zlar: quruq ko‘z sindromi, BUT testi, Schirmer testi, ko‘z yoshi plyonkasi, omega-3, sun’iy ko‘z yoshi.Abstract
Annotatsiya. Ushbu tadqiqotda quruq ko‘z sindromi bilan og‘rigan bemorlarda
turli davolash usullarining ko‘z yoshi plyonkasi barqarorligiga ta’siri qiyosiy tahlil
qilindi. Tadqiqotga 20 nafar bemor jalb etildi va ular ikki guruhga bo‘lindi: sun’iy ko‘z
yoshi tomchilari bilan davolash hamda kombinatsiyalangan (sun’iy ko‘z yoshi +
omega-3 qo‘shimchalar) terapiya. Ko‘z yoshi plyonkasi barqarorligi BUT (Break-Up
Time) testi orqali baholandi. Natijalar kombinatsiyalangan terapiya ko‘z yoshi
plyonkasi barqarorligini sezilarli darajada yaxshilashini ko‘rsatdi.
References
Adabiyotlar ro‘yxati
1. TFOS DEWS II. Report of the Tear Film and Ocular Surface Society Dry
Eye Workshop II // The Ocular Surface. – 2017. – Vol. 15, № 3. – P. 276–283.
2. Craig J.P., Nichols K.K., Akpek E.K. et al. TFOS DEWS II Definition and
Classification Report // The Ocular Surface. – 2017. – Vol. 15, № 3. – P. 276–283.
3. Pflugfelder S.C., de Paiva C.S. The Pathophysiology of Dry Eye Disease
// American Journal of Ophthalmology. – 2021. – Vol. 217. – P. 1–12.
4. Bron A.J., de Paiva C.S., Chauhan S.K. et al. TFOS DEWS II
Pathophysiology Report // The Ocular Surface. – 2017. – Vol. 15, № 3. – P. 1–20.
5. Lemp M.A. Report of the National Eye Institute/Industry Workshop on
Clinical Trials in Dry Eye // CLAO Journal. – 2020. – Vol. 46, № 2. – P. 123–130.
6. Nichols K.K., Foulks G.N., Bron A.J. The International Dry Eye
Workshop // Cornea. – 2019. – Vol. 38, № 1. – P. 1–8.
7. Maissa C., Guillon M. Tear film evaluation methods // Contact Lens &
Anterior Eye. – 2018. – Vol. 41, № 3. – P. 210–216.
8. Messmer E.M. The pathophysiology, diagnosis, and treatment of dry eye
disease // Deutsches Ärzteblatt International. – 2015. – Vol. 112, № 5. – P. 71–82.
9. Stapleton F., Alves M., Bunya V.Y. et al. TFOS DEWS II Epidemiology
Report // The Ocular Surface. – 2017. – Vol. 15, № 3. – P. 334–365.
10. Paulsen A.J. Meibomian gland dysfunction and tear film instability //
Survey of Ophthalmology. – 2020. – Vol. 65, № 4. – P. 400–410.
11. Wolffsohn J.S., Arita R., Chalmers R. et al. TFOS DEWS II Diagnostic
Methodology Report // The Ocular Surface. – 2017. – Vol. 15, № 3. – P. 539–574.
12. Schaumberg D.A., Sullivan D.A., Dana R. Epidemiology of dry eye
syndrome // Cornea. – 2016. – Vol. 35, № 3. – P. 324–330.
13. Korb D.R., Blackie C.A. Meibomian gland function and dry eye treatment
// Optometry and Vision Science. – 2018. – Vol. 95, № 6. – P. 487–493.
14. Lemp M.A., Foulks G.N. Clinical implications of tear film instability //
American Journal of Ophthalmology. – 2019. – Vol. 208. – P. 20–28.
15. Clayton J.A. Dry eye: etiology and management approaches // New
England Journal of Medicine. – 2021. – Vol. 384, № 7. – P. 654–662.
